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Abstract 
Peptides are excellent building blocks to form precise nanostructures by self-assembly. 
They can self-assemble into fibril nanostructures, thus recreating some of the 
architectural features of the natural extracellular matrix. Here, we used a microfluidic 
approach to drive the self-assembly of peptides of opposite charge into capsular 
structures for cell encapsulation. The obtained capsules presented a core shell 
structure made of a network of nanofibers and their properties can be tuned by 
varying the concentration of each peptide. Capsules were found to be stable in 
aqueous solutions and their permeability dependent on the capsule composition. 
Human dermal fibroblasts were encapsulated and remained viable within the capsules 
and their morphology was shown to be influenced by the matrix density. Additionally, 
these capsules also supported the co-culture of fibroblasts and keratinocytes. We 
expect that the developed peptide-based microcapsules can serve as miniaturized 
environments for cell culture and as biomimetic platforms for in vitro drug screening. 
Page 2 of 44Soft Matter
 Keywords: electrostatic self-assembly, peptide-amphiphiles, microfluidics, directed 
self-assembly, soft capsules, cell culture.  
Page 3 of 44 Soft Matter
1. Introduction 
Molecular self-assembly, the spontaneous organization of molecules into ordered 
aggregates by noncovalent interactions, is becoming increasingly important in the 
development of new biomaterials because it offers a great platform for constructing 
materials with high level of precision and complexity.
1, 2
 Although bulk self-assembly of 
small molecules frequently yields structures that exhibit a high degree of order on the 
nanometer scale, they exhibit more disordered morphologies at the micrometer scale. 
However, recent research has demonstrated the feasibility of using electrostatic 
interactions between small molecules and high molecular weight polymers to drive 
their assembly into larger assemblies that can extend over multiple length scales.
3
 On 
the other hand, directed self-assembly (DSA) has emerged as strategy to control order 
in materials across scales by tuning the directionally of self-assembly interactions at 
the nanoscale.
4
  In DSA the positions of self-assembling building blocks are guided by 
an external input to introduce hierarchical organization in supramolecular materials. 
Examples of external inputs include mechanical forces, such as shear effects
5
, 
magnetic
6
 and electric
7
 fields, thermal gradients
8
 and chemically
9
 or topographically
10
 
patterned substrates. Although the concept of DSA still remains ambiguous, templated 
self-assembly (TSA) can be considered  as a kind of DSA, in which a prefabricated 
‘‘template’’ orients and directs the assembling components.
11
 Another approach 
towards DSA is the use of geometric confinement to orient bulk structures or to induce 
the formation of novel morphologies not found in bulk systems. For example, 
microfluidics has been used to guide the self-assembly of block copolymers,
12
 and in 
the synthesis of liposomes
13
 and microcapsules,
14
 thus providing additional control 
over the size and shape of self-assembled structures.  
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It is widely understood that in order to encapsulate living cells within an artificial 
matrix, the encapsulating conditions must not damage the cells and the matrix 
material must be biocompatible and at the same time provide a natural 
microenvironment for the cells to sustain their viability, function and growth. The 
mechanical strength of the encapsulating matrix is also critical for maintaining the 
matrix integrity and to withstand manipulations associated with in vitro culture. 
Moreover, it is essential that the matrix should have suitable diffusion properties to 
ensure sufficient access of nutrients, for encapsulated cells to remain viable and 
functional, and the removal of secreted metabolic waste products. Thus, there is a 
need for relatively mild cell encapsulation methods, which offers control over 
properties of the encapsulating matrix. An exciting approach for cell encapsulation is 
the use of materials that can undergo gelation in cell-compatible conditions. Hydrogels 
are appealing for cell encapsulation because they are highly hydrated three-
dimensional networks that provide an environment for cells to adhere, proliferate, and 
differentiate and they can often be processed under relatively mild conditions. 
Gelation can occur through a change in temperature, or via chemical crosslinking, ionic 
crosslinking, or formation of an insoluble complex.
15
 
Self-assembling materials, not depending on covalent chemistry, enable the direct cell 
encapsulation under mild conditions. Within self-assembled nanomaterials, peptide 
nanostructures can present varied geometries (e.g. micelles, nanofibers, vesicles)
16, 17
 
and chemical diversity for biological recognition. Peptides are, therefore, excellent 
structural units to form complex nanostructures that can recreate some of the 
architectural features and functionalities of the natural extracellular matrix (ECM).  
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Previous work from the Stupp lab demonstrated the self-assembly of peptide-
amphiphile (PA) molecules of opposite charges into nanofibers by electrostatic 
attraction at neutral pH.
18
 Mixing solutions of oppositely charged PAs resulted in 
nanofiber formation and at certain concentration transformed into a 3D gel. Ionic 
interactions between positively charged and negatively charged moieties within the 
peptides has been explored as a self-assembly mode.
19-21
  
Cell microencapsulation is a technology with enormous clinical potential for the 
production of biologically important therapeutics and the treatment of a wide range of 
diseases.
22
 The encapsulation of cells in microscopic gel capsules can also be used for 
exploratory purposes in biology, to study the role of specific microenvironments on 
cell fate, create cell arrays for single-cell bioassays and for drug screening.
23
 To 
optimize the performance of microgel capsules, it is crucial to control size, shape and 
the content of encapsulated additives. The use of emulsion droplet as templates for 
microgel synthesis has been widely explored.
23-25
 The principle of this technique is to 
use micrometer-scale channels to carry a solution of a microgel precursor. The stream 
of the precursor solution can be broken up by flow focusing with continuous phase of 
an immiscible fluid, normally an oil phase. When these two fluids meet, droplets are 
formed, drop-by-drop, due to the interfacial tension and the shear of the continuous 
phase. By varying the microchannel geometry, the flow rates and viscosities of the 
fluids, monodisperse droplets with controlled size can be generated. The subsequent 
droplet gelation allows retaining their morphology. Thus, the main goal of the present 
study was to produce soft peptide microgel capsules with controlled properties for cell 
encapsulation and culture. Towards this goal, we used droplet-based microfluidics to 
guide the electrostatic self-assembly of peptides of opposite charge and generate 
Page 6 of 44Soft Matter
capsules with controlled spherical shape and monodisperse size. The structure and 
properties of the obtained peptide capsules are described, as well as their application 
as 3D matrix for conducting different cell culture studies (e.g. cell-matrix interactions, 
co-culture).  
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2. Materials and methods 
Peptide synthesis and purification 
Two peptide amphiphiles (PAs) with opposite charge were synthesized in this work, 
consisting of a peptide segment covalently linked to a 16-carbon alkyl chain: C16-V3A3K3 
(K3-PA) and C16-V3A3E3 (E3-PA) (Fig. 1). The peptides were synthesized on a CS Bio 
136XT automated peptide synthesizer (CS Bio, USA) using standard 9-
fluorenylmethoxycarbonyl (Fmoc) based solid phase chemistry. K3-PA was synthesized 
on a 4-methylbenzhydrylamine (MBHA) rink amide resin (Novabiochem, Germany) and 
E3-PA on a 4-benzyloxybenzylamine Wang resin pre-loaded with the first glutamic acid 
(Fmoc-Glu(OtBu)-Wang resin). Amino acid couplings were performed using 4 
equivalents (4 mmol) of Fmoc protected amino acids (Novabiochem, Germany), 4 
equivalents of O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium 
hexafluorophosphate (HBTU, Novabiochem®) and 6 equivalents of N,N-
diisopropylethylamine (DIEA, Sigma, USA). Fmoc deprotections were performed with 
20% piperidine (Sigma, USA) in dimethylformamide. A palmitic acid (C16H32O2, 
Calbiochem, Germany) tail was manually coupled under the same conditions as the 
Fmoc-amino acids. Peptide cleavage from the resin and removal of the protecting 
groups was carried out on a mixture of trifluoroacetic acid (TFA, Sigma, 
USA)/triisopropylsilane (TIS, Alfa Aesar)/water (95/2.5/2.5)) for 3 h at room 
temperature. The peptide mixture was collected and excess of TFA was removed by 
rotary evaporation. The resulting viscous peptide solution was triturated with cold 
diethyl ether and the white precipitate was collected by filtration, washed with cold 
ether, and allowed to dry under vacuum overnight. The peptide mass was confirmed 
by matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS, 4800 
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MALDI-TOF/TOF, AbSciex). Peptides were then purified on a Waters 2545 Binary 
Gradient high-performance liquid chromatography (HPLC) system using preparative 
reverse-phase C18 columns. K3-PA was purified on an Atlantis Prep OBD T3 column 
(Waters) with a water/acetonitrile (0.1% TFA) gradient and E3-PA on a Xbridge column 
(Waters) with a water/acetonitrile (0.1% NH4) gradient. For K3-PA, TFA counter-ions 
were exchanged by sublimation from 0.01 M hydrochloric acid. Finally, the peptides 
were dialyzed against ultrapure water using 500 MWCO dialysis tubing (Spectrum labs, 
The Netherlands), lyophilized and stored at -20 ºC until further use. Confirmation of 
mass and purity was done by MALDI-MS and HPLC (Supplementary Information, Fig. 
S1-S2). Peptide solutions used in cell culture studies were sterilized by UV exposure for 
15 minutes. 
 
Preparation of peptide-based capsules 
Capsules were generated using a microfluidic device developed in our lab that allows 
the production of stable and size-controlled spherical capsules.
26
 This system can be 
conveniently cleaned and sterilized allowing cell encapsulation in a sterile 
environment, reducing contamination risks during the procedure. A solution of E3-PA 
(1 wt%) in 0.15 M NaCl was first and injected into one of the microchannels of the 
microfluidics device using a syringe pump (Alladdin WPI, England). Simultaneously, 
mineral oil was provided to the oil microchannel from a reservoir using a low speed 
peristaltic pump (Ismatec, Switzerland). The operation rates of the peristaltic and 
syringe pumps were set at 50 µL/min and 20 µL/min, respectively. The peptide 
microdroplets were generated inside the microfluidics device by shear stress when the 
E3-PA solution in the horizontal microchannel entered into the stream of mineral oil in 
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the larger vertical microchannel (Fig. 1A). The formed microdroplets were collected 
from the outlet tubing in a separate vessel containing 1 mL of K3-PA solution (0.1, 0.2 
and 0.5 wt%) in 0.1 M CaCl2. 10 µL of Tween-80 was added as a surface-active agent to 
prevent aggregation of the capsules. Capsules were incubated in the K3-CaCl2 solution 
for 15 minutes and washed three times with 0.15 M NaCl. 
 
Capsule characterization 
Phase contrast microscopy 
Microscopic observations of the capsules were carried out to examine their size and 
shape. Phase contrast micrographs of the capsules were acquired in an inverted 
microscope (Axio Observer, Zeiss, Germany). The size of the capsules was then 
estimated by measuring the diameter of individual capsules (n=30). 
 
Scanning electron microscopy (SEM) 
The microstructure of the capsules was analyzed by SEM. Samples were fixed in a 2% 
glutaraldehyde/3% sucrose in PBS for 1 h at 4 ºC followed by sequential dehydration in 
graded ethanol concentrations (from 20 to 100%). To remove ethanol, samples were 
dried in a Tousimis Autosandri®-815 (series A) critical point dryer. To expose the 
internal surface of the capsules, they were cut into half with a sharp blade. Prior 
observation, the samples were coated with a gold/palladium layer and imaged using 
an ultra-high resolution field emission gun scanning electron microscope (Nova™ 
NanoSEM 200) from FEI (Eindhoven, The Netherlands).  
 
Swelling 
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The stability of the capsules in aqueous environment was studied by incubating them 
in water and PBS. Capsules (n=10/well, in triplicate) prepared with 0.1, 0.2 and 0.5% 
K3-PA were distributed in a 24 well plate and 1 mL of ultrapure water or PBS was added 
to each well. Samples were incubated at 37 ºC and at predetermined time points (1, 2, 
3 and 7 days) capsules were observed in an inverted microscope (Axio Observer, Zeiss, 
Germany) and their size was measured using ZEN software (Zeiss, Germany) . 
 
Mechanical stability 
To study the mechanical stability of the different capsules, 10 capsules (in triplicate) 
were placed in 12 well plates containing 2 mL of PBS and 10 glass beads (3 mm 
diameter, VWR) . The plate was placed in a flat rotator (DSR-2800 V, Digisystem 
Laboratory Instruments Inc., Taiwan) shaking at about 200 rpm. At predetermined time 
points (2, 4 6 and 24 h), the number of intact capsules was counted by observation in 
an inverted microscope (Axio Observer, Zeiss, Germany). The percentage of intact 
capsules as a function of time was determined by calculating the ratio between the 
number of intact capsules at each time point and the initial number.  
 
Permeability 
The capsule permeability was investigated by using dextran standards of different 
molecular weights (20, 40 and 155 kDa). For that, FITC- and TRITC-labeled dextrans 
(Sigma, USA) were encapsulated within the capsules and their release followed along 
the time. Three different solutions were prepared; each solution was a mixture of 0.5 
mg/mL of dextran (20, 40 and 155 kDa) with 1 wt% E3-PA. The mixture was injected 
into the microfluidic device and capsules were generated as described before. The 
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capsules were then placed in PBS (pH 7.4) at 37 ºC in a water bath with agitation. At 
specific time intervals, the release medium was completely collected for further 
analysis and replaced with the same amount of fresh PBS solution. The fluorescence 
was measured at 485/528 nm (FITC-labeled) and 530/590 nm (TRITC-labeled) on a 
microplate reader (BIO-TEK, Synergie HT, USA). The concentration of released dextran 
was measured using a calibration curve using known concentrations of dextran 
solutions. 
 
Cell culture and encapsulation 
Isolation and culture of human dermal fibroblasts and epidermal keratinocytes 
Human dermal fibroblasts (hDFb) and epidermal keratinocytes (hKc) were isolated 
from skin samples discarded from abdominoplasty surgeries of consenting patients at 
Hospital da Prelada (Porto, Portugal). Briefly, the skin tissue was cut in pieces of 0.5 by 
0.5 cm and digested in a dispase solution (2.4 U/mL in PBS) at 4 ºC, overnight. After 
dissociation of the epidermis from the dermis, keratinocytes were isolated by a 5 
minute digestion of the epidermis in 0.25% trypsin/EDTA (Invitrogen, UK) at 37 ºC to 
release the cells. Trypsin was inactivated by the addition of the same volume of fetal 
bovine serum (FBS, Gibco, UK), the digestion products were poured through a 100 µm 
cell strainer and centrifuged at 200 g for 5 minutes. Cell pellet was washed with 
phosphate buffered saline (PBS, Gibco, UK)) and centrifuged at 200 g for 5 minutes. 
The pellet was resuspended and the cells were subsequently cultured in Keratinocyte 
Serum Free Medium (KSFM, Gibco, UK) with L-glutamine and keratinocyte-SFM 
supplement (Gibco, UK), in a 37 ºC humidified atmosphere with 5% CO2. Fibroblasts 
were isolated from the dermis by overnight digestion of the dermal pieces in a 
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collagenase IA solution (125 U/mL in PBS) at 4 ºC. Digestion products were poured 
through a 100 µm cell strainer and centrifuged at 200 g for 5 minutes. The pellet was 
resuspended and the cells were subsequently cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) (Sigma, Germany) supplemented with 10% FBS (Gibco, UK) and 1% 
(v/v) antibiotic/antimycotic solution (A/B) (Gibco, UK) containing 100 units/mL 
penicillin and 100 mg/mL streptomycin, in a 37 ºC humidified atmosphere with 5% 
CO2. Cells used in this study were between passage 2 and 4 (hDFb) and passage 1 and 2 
(hKc). 
 
Encapsulation and culture of hDFb within capsules 
Confluent hDFb were harvested from monolayer cultures using trypsin-EDTA 
(Invitrogen, USA). Cells were washed in PBS and centrifuged at 200 g for 10 minutes to 
remove calcium residues from the medium. Cell pellet was then resuspended at a 
density of 1.0 x 10
6
 cells/mL
 
in 1 wt% E3-PA solution. Capsules were generated as 
described before, using a 0.1 wt% K3-PA solution supplemented with 0.1 M CaCl2. 
Capsules were transferred to 24-well plates and cultured up to 14 days in DMEM 
without phenol red (Sigma) supplemented with 10% FBS (Gibco, UK) and 1% (v/v) A/B 
(Gibco, UK), in a 37 ºC humidified atmosphere with 5% CO2. Fibroblast morphology and 
interaction with the artificial matrix were also investigated as a function of matrix 
composition by varying E3-PA concentration. Cell pellet was resuspended at a density 
of 1.0x10
6
 cells/mL in E3-PA solutions (0.5, 1 and 2 wt%) in NaCl. At predetermined 
time points, samples were collected to assess cell viability (live/dead assay), 
morphology and spreading (SEM, F-actin and collagen I staining). 
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Live/Dead staining 
Cell viability was assessed through live/dead assay using calcein-AM (Sigma) and 
propidium iodide (PI, Molecular Probes, Invitrogen, USA) dyes. Calcein-AM is a 
membrane-permeant dye, which is hydrolyzed by endogenous esterase into the highly 
negatively charged green fluorescent cell marker calcein retained in the cytoplasm. 
Propidium iodide is a membrane impermeant, thus binding to DNA of dead cells. At 
each time point, medium was removed and 1 mL of PBS containing 2 µL of calcein-AM 
and 1 µL of PI was added to each well. Samples were incubated for 10 minutes at 37 ºC 
protected from light followed by three washes in PBS, and were immediately visualized 
in a fluorescence microscope (Axioimage RZ1M, Zeiss, Germany). 
 
Staining and confocal microscopy  
For examining the morphology of encapsulated hDFbs within the different capsules, 
staining for collagen I and e F-actin was carried out after fixing cells in 10% formalin 
solution (Sigma-Aldrich, Germany) for 30 minutes at 4 ºC. Cells were then washed once 
with 0.1 M Glycine in PBS and twice with PBS and permeabilized with 2% BSA/ 0.2% 
Triton X-100 solution for 1 h at RT. Samples were incubated with primary antibody 
anti-collagen I (ab292, 1:500, abcam, UK) for 1 h at RT and washed three times for 2 
minutes with PBS. Samples were then incubated with the secondary antibody, anti-
mouse Alexa 488 (1:200, Molecular Probes, Invitrogen, USA) for 1 h at RT. In some 
cases, samples were treated with TRITC-conjugated phalloidin (1 U/mL, Sigma-Aldrich, 
Germany) for 1 h at RT. Cell nuclei were counterstained with 1 mg/mL DAPI (1:1000, 
Sigma-Aldrich, Germany) for 1 min and washed with PBS. Visualization was performed 
by confocal laser scanning microscopy (CLSM,Olympus FluoView 1000, Olympus, 
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Japan). Background was subtracted and images were processed using FV10-ASW 3.1 
software (Olympus, Japan). 
 
Cell proliferation 
Cell proliferation within the capsules was assessed at different culture times (1, 3, 7 
and 14 days) by quantifying the amount of double-stranded DNA (dsDNA). Samples 
were prepared as described elsewhere
27
. Briefly, capsules were lyophilized and 
resuspended in phosphate-buffered EDTA (pH 6.5) supplemented with 0.01 M L-
cysteine (Sigma, USA) and 0.5% papain (Sigma, USA). Digestion was performed at 60 ºC 
for 24 h. Following this, quantification was performed using the Quant-iT
™
 PicoGreen
®
 
dsDNA Assay Kit (Invitrogen, Molecular Probes, Oregon, USA), according to the 
instructions of the manufacturer. The fluorescent intensity of the dye was measured in 
a microplate reader (Synergie HT, Bio-Tek, USA) with excitation at 485/20 nm and 
emission at 528/20 nm. The DNA concentration for each sample was calculated using a 
standard curve (DNA concentration ranging from 0 to 1.5 mg/mL) relating quantity of 
DNA and fluorescence intensity. The fluorescence signals obtained from blank capsules 
(i.e. without cells, cultured and processed similarly to those with cells) were used as 
background values (blanks). Triplicates were made for each time point and for each 
sample (n=10 capsules/sample). 
 
Co-culture studies - seeding of keratinocytes on the surface of the capsules with 
encapsulated fibroblasts 
To validate our peptide capsules for co-culture studies, hDFb and hKc were co-cultured 
within and on the capsule surface, respectively. Encapsulation of hDFb capsules was 
Page 15 of 44 Soft Matter
processed as described previously. Capsules were transferred to 6-well plates and 
cultured in DMEM without phenol red, supplemented with 10% FBS and 1% A/B. After 
1 day, keratinocytes were seeded on the capsules (5x10
5
 cells/well) and cultured on a 
25:75 mixture (previously optimized in monoculture) of DMEM (containing 10% FBS, 
1% A/B) and keratinocyte serum free medium with supplements in a 37 ºC humidified 
atmosphere with 5% CO2. Cells were examined under SEM to analyze cell morphology 
and cell-matrix interactions. Samples were fixed, dehydrated and prepared as 
described for SEM analysis. Co-cultured cells were also characterized using an 
immunocytochemistry assay with specific markers for each cell type. Samples were 
fixed and prepared as described previously. The primary antibodies and dilutions used 
in the assay were anti-fibroblast surface protein (F4771, 1:500, Sigma, USA) and anti-
keratin 5 (PRB-160P, 1:500, Covance, Spain). The secondary antibodies and dilutions 
were anti-rabbit Alexa 488 (1:200) and anti-mouse Alexa 594 (1:500) (Molecular 
Probes, Invitrogen, USA). Samples were visualized by CLSM (Olympus FluoView 1000, 
Olympus, Japan). Background was subtracted and images were processed using FV10-
ASW 3.1 software (Olympus, Japan). 
 
Data analysis and statistics 
All data values are presented as mean ± standard deviation (SD). Statistical analysis 
was performed using GraphPad Prism 5.00 software (San Diego, USA). Statistical 
differences were determined using one-way analysis of variance (ANOVA) with a 
Bonferroni’s multiple comparisons post-hoc test (Permeability, DNA quantification). 
Differences between groups in the mechanical stability study were determined using a 
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two-way analysis of variance (ANOVA) with a Bonferroni’s multiple comparisons post-
hoc test. ( ∗ p < 0.05, ∗ ∗ p < 0.01 and ∗ ∗ ∗ p < 0.001) 
3. Results and discussion 
Building blocks for electrostatic driven-self-assembly 
The self-assembling peptides used in this study are amphiphilic molecules, composed 
of a hydrophobic segment coupled to a peptide sequence, that includes a β-sheet 
forming sequence (VVVAAA) and a domain with charged amino acids, either positive 
(KKK, K3-PA, Fig. 1B) or negative (EEE, E3-PA, Fig. 1A).
27
 
The negatively charged peptide (E3-PA) was chosen by its known ability to undergo 
self-assembly into nanofribrillar structures in the presence of divalent cations, such as 
Ca
2+
, and form stable gels at certain concentrations.
8, 27, 28
 It has been shown that self-
assembling peptide gels present a nanofibrillar network that resemble de structural 
architecture of extracellular matrix, making them attractive for studying cell-matrix 
interactions on a 3D environment.
29-31
 Electrostatic-driven self-assembly between PAs 
of opposite charge was demonstrated by the formation of nanofibers with subsequent 
formation of self-supporting gels.
18
 Based on these findings, we hypothesized that 
microfluidic technology could be used to control the size and microscopic shape of 
nanostructures generated by electrostatic self-assembly. Peptide droplets generated in 
the microfluidic device would serve as templates to produce spherical capsular 
structures by self-assembly (Fig. 1). The core and shell of the proposed capsules can be 
further tailored by changing the peptide concentration and/or the conditions during 
the self-assembly process, for example the pH, as it is known that pH affects the 
charge of peptides. For example, Savin and Doyle
19
 studied the effect of pH on the 
kinetics of self-assembly of a model peptide containing positively charged and 
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negatively charged residues. Using multiple particle tracking, they found that 
increasing the pH of the peptide solution from 3.5 to 4.0, the gelation time decreased 
by almost hundredfold. By incorporating bioactive moieties in the peptide sequences, 
these peptide capsules can offer a versatile artificial matrix to encapsulate cells and 
study their behavior under different physical and biochemical signals. 
 
Capsule generation by directed self-assembly 
In the present work, we have used a microfluidic method to generate spherical 
capsular structures by self-assembly between oppositely charged peptides for the 
encapsulation of human dermal fibroblasts.  
The first step in capsule preparation requires the formation of microdroplets of an 
aqueous solution of a negatively charged peptide (E3-PA, 1 wt%) in the microfluidic 
device through emulsification in the oil phase (Fig. 1A). The E3-PA microdroplets were 
then directly extruded into a solution of a similar peptide with opposite charge (Fig. 
1B). The peptide microdroplets formed in the oil phase served as templates for the 
formation of stable spherical capsules by electrostatic self-assembly between the E3 
and K3 PAs. The microfluidics device was used to control/guide the interfacial self-assembly 
between the two peptides to obtain a final microstructure with a spherical shape, instead their 
“chaotic” self-assembly in solution. Here, the shape and size of the peptide droplet, formed in 
the microfluidic device, determines the final morphology of the assembly. At the droplet 
interface, self-assembly immediately occurs resulting on the formation of a capsular 
structure (a wall membrane made of K3-E3-PA nanofibers with a liquefied core 
containing free E3-PA molecules – Fig. 1C). The oil phase separates from the K3-PA 
solution and floats to the surface because of the difference in densities. This phase 
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separation allows the aqueous peptide droplets to be dispersed in the K3-PA solution 
(below the oil phase). The mineral oil is removed from the collection vessel by 
pipetting out the upper layer. The K3-PA solution was supplemented with 0.1 M CaCl2 
to induce the gelation of internal E3-PA (Fig. 1D). To further control the microstructure 
and permeability of the capsule wall, the concentration of K3-PA was varied (0.1, 0.2, 
0.5 wt%). 
The morphology and microstructure of the generated capsules were analyzed with 
phase contrast microscopy and SEM. Their stability, mechanical resistance, 
permeability and ability to support the encapsulation and survival of human dermal 
fibroblasts were also studied. 
 
Capsule characterization 
Size, morphology and microstructure  
Images obtained by phase contrast microscopy showed spherical shaped capsules with 
uniform size and a diameter of around 1000 µm (Fig. 2A). Higher concentrations of K3-
PA (> 1 wt%) generated larger capsules with a dense shell that would difficult the 
diffusion of nutrients and cell metabolites, leading to the formation of necrotic centers 
and cell death. On the other hand, lower concentrations, ranging from 0.1 to 0.5 wt%, 
resulted in stable capsules. SEM micrographs of the capsules showed a shell with a 
nanofibrillar structure (Fig. 2B) as a result from the self-assembly between the 
peptides. The external surface of the capsules exhibit a network of nanofibers 
randomly distributed but the nanofiber density was higher for the capsules formed at 
higher concentration of K3-PA. This observation showed that we were able to 
modulate capsule shell microstructure by varying K3-PA concentration, which may have 
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implications on the capsule permeability. Furthermore, this external membrane 
enables the protection of encapsulated species from the external environment. The 
capsules can have either a liquid (Fig. 1C) or gel core after gelation with Ca
2+
 ions (Fig. 
1D), allowing to create different cellular microenvironments, either for culturing cells 
in suspension or anchorage-dependent cells. Liquid core capsules were less stable and 
more susceptible to burst, whereas core gelation generates robust capsules using 
concentrations of E3-PA from 0.5 to 2 wt%. To assess the internal surface, capsules 
were fractured before SEM imaging. SEM micrographs showed a dense core with a 
random fibrillar structure (Fig. 2C).  
 
Swelling, mechanical stability and permeability 
A general requirement for capsules as 3D environments for cell encapsulation and 
culture include their mechanical and chemical stability in aqueous media (e.g. buffer, 
cell culture medium). To investigate whether capsules were able to maintain their 
structural integrity when exposed to aqueous solutions, capsules were incubated in 
water or PBS and their size variation was followed for 7 days. Capsules were shown to 
be very stable in both solutions, without relevant size variation along time (Fig. 3A). 
Capsules with lower swelling rate are less prone to rupture and to induce an 
inflammatory response when implanted in vivo.
32
 To evaluate capsules mechanical 
stability, an additional study was performed. Capsules were incubated in PBS with 
glass beads under agitation and their membrane integrity was followed for 24 h. As 
expected, capsules formed at higher concentration of K3-PA (0.5 wt%), with a denser 
outer shell, showed to be less prone to damage (Fig. 3B), although the difference 
between conditions is more notorious only after 24 h. 
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Capsules permeability is crucial for cell encapsulation to allow the diffusion of oxygen, 
nutrients and cell metabolites. Additionally, when used for cell delivery therapies, they 
should also be able to avoid the influx of immune cells and antibodies. To assess the 
effect of K3-PA concentration on the permeability of the capsules, dextran standards of 
different molecular weights (20, 40, 155 kDa) were encapsulated within the capsules 
and their release followed with time. The release profile of 20 kDa dextran was similar 
for all the conditions and faster than the dextran with higher MW, as expected, and 
after 24 h about 60% of the encapsulated dextran was released from the capsules (Fig. 
3C). For the 40 kDa dextran, a similar behavior was observed for the capsules with 0.1 
and 0.2 wt% K3-PA. After 24 h, about 50% of the encapsulated dextran was released. 
The percentage of dextran released from the capsules formed with 0.5 wt% K3-PA was 
lower (40%) as expected (Fig. 3C). The diffusion of the higher MW dextran (155 kDa) 
was slower. After 24 h, only 20-25% of the encapsulated dextran was released in all 
the conditions (Fig. 3C). These results indicate that capsules formed in higher peptide 
concentration exhibit a controlled diffusion of high molecular weight molecules.  
This difference in the capsule permeability may be related to their microstructure 
observed by SEM (Fig. 3C, Fig. S3). Capsules formed with higher concentration of K3-PA 
showed a shell structure with a much denser nanofibrillar organization which may 
hamper the diffusion of larger molecules. Estimation of the porosity of the capsule 
external surface also confirmed higher porosity for the capsules prepared with lower 
peptide concentrations (Supplementary Information, Fig. S4). By varying the 
concentration of one of the components (K3-PA) we were able to modulate the capsule 
wall porosity and permeability. 
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Encapsulation and culture of hDFb within capsules 
Most of cell-matrix interactions in vivo occur in 3D environments, with the cells 
normally embedded within an ECM that is constantly undergoing remodelling by the 
cells themselves. The potential of the developed capsules as 3D scaffolds for 
anchorage-dependent cells was investigated by the encapsulation of human dermal 
fibroblasts. 
 
Cell viability and proliferation 
A fluorescence live/dead assay was performed to assess the viability of encapsulated 
cells. Living (green) cells with well-defined round contours were visualized and no dead 
cells (shown as red nuclei) were detected within the capsules. Furthermore, cells 
remained viable and well distributed within the capsules throughout the 14 days of 
culture (Fig. 4B). 
The quantification of DNA (Fig. 4A) revealed a gradual increase in DNA as a result of 
fibroblast proliferation over time. These results demonstrate that the capsule 
composition and the method to obtain them did not affect cell viability. 
 
Expression of collagen I 
Fibroblasts have the natural ability to remodel their extracellular microenvironment by 
either expressing proteolytic enzymes or synthesizing ECM proteins, such as collagen 
I.
33
 The ability of fibroblasts to synthesize collagen I was assessed by 
immunofluorescence, as an indirect way to evaluate encapsulated fibroblasts 
functionality. Confocal microscopy images showed that cells maintained the ability to 
produce collagen I during the culture time (Fig. 4C2,C3). 
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 Cell morphology 
The morphology of fibroblasts within the capsules was assessed by SEM. Micrographs 
showed round-shaped cells in the capsules inside cavities, that reflect the living spaces 
preserved by the cells (Fig. 4D). In the SEM images, cell size can be estimated to be 
around 10 µm. A thin fiber-like matrix secreted by the cells was visible shortly after 
one day. The presence of these protrusions was more evident after 14 days of culture, 
showing the interaction of the fibroblasts with the nanofibrillar structure of the gelled 
E3-PA. Although fibroblasts were still interacting with the fibrillar matrix of the self-
assembled peptide, cells still remained round after 14 days of culture. Based on this 
observation, and previous findings on the effect of matrix properties on fibroblast 
proliferation in 3D gels,
34
 which showed that at higher stiffness the matrix acts as 
physical barrier for cells in 3D, impeding their proliferation and migration, we have 
further investigated the influence of peptide concentration inside the capsules on the 
morphology of encapsulated fibroblasts. 
 
Influence of matrix composition on fibroblast morphology 
Fibroblast morphology and cell-matrix interactions were investigated by varying the 
percentage of E3-PA (0.5, 1 and 2 wt%) inside the capsule. Previous studies using 
collagen matrices prepared under diverse conditions showed that matrix stiffness 
increases with matrix density.
35
 Here, we intended to modulate the matrix density in 
the capsules core by varying peptide concentration. SEM micrographs of the capsules 
interior confirmed our hypothesis revealing a higher density of fibrillar nanostructures 
with increasing concentration of E3-PA (Fig. 5A). SEM micrographs of encapsulated 
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fibroblasts within 1 and 2 wt% E3-PA showed round shaped cells interacting with the 
nanofibrillar structure of the gelled peptide, similar to what we have observed before 
(Fig. 5B). In contrast, within 0.5 wt% E3-PA capsules, cells remained round after 1 day, 
but after 7 days, fibroblasts had spread out exhibiting extended protrusions interacting 
with fibrillar structure of E3-PA. When cultured in 0.5 wt% E3-PA, cells adopted a 
spindle shape with fine filopodia. After 14 days, the spread cells formed a 3D-network 
and phalloidin-stained F-actin showed highly elongated cells with clearly-defined stress 
fibers (Fig. 5C). In contrast, cells cultured in 1 and 2 wt% E3-PA capsules maintained a 
spherical shape, and phalloidin staining showed peripheral deposition or poorly 
organized F-actin that followed the cell contours. As previously observed, fibroblasts 
maintained their ability to synthesize collagen I. Within 0.5 wt% E3-PA capsules, 
collagen I has a strong signal and was well distributed in the cytosol, whereas in 1 and 
2 wt% E3-PA the signal was weaker and collagen distribution was more peripheral. 
These results show a similar trend to what has been observed by Bott and co-
authors,
34
 when studying the effect of matrix stiffness on fibroblast proliferation in 3D 
gels. It has been shown that fibroblasts normally exhibit a flat morphology with dorsal-
ventral polarity and extended protrusions when cultured in 2D
36, 37
 because when they 
migrate and proliferate they do not experience major physical barriers.
38
 However, 
when encapsulated in a 3D matrix, fibroblasts need to overcome barriers posed by the 
surrounding environment to proliferate and migrate, re-acquiring a natural spindle-
shaped morphology.
36-38
 These results highlight the role of the core matrix 
density/stiffness in controlling cell morphology and cell-matrix interaction. 
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Co-culture studies – culture of hKC over the surface of the peptide capsules 
encapsulating hDFb  
In vitro co-culture systems, using relevant cell types, can serve as mimics of tissue 
niches found in vivo and be used as valuable tools for probing and manipulating cell-
cell interactions. Since interactions between cells can occur through soluble factors via 
paracrine signaling, co-culture studies should be performed in interactive 
microenvironments to permit the exchange of soluble factors between neighboring 
cells, while maintaining the different cells physically separated. In addition, these 
microenvironments should recreate the composition and structure of native ECMs. By 
using gelled core peptide capsules with a fibrillar structure, we have demonstrated 
that hDFb could be encapsulated within the capsules and were able to survive for 14 
days. To further demonstrate the ability of these capsular structures for conducting 
more complex cellular studies (e.g. co- culture) we investigated their ability to support 
the co-culture of hDFb and hKc, within and on the capsule surface, respectively (Fig. 
6A). The hKc gradually adhered to the capsule surface and covered it after 24 h, 
resulting in hDFb-hKC co-cultured capsules, as seen in phase contrast microscopy 
images (Fig. 6B1). Confocal microscopy images of the capsules stained with antibodies 
specific for each cell type (Fig. 6B2-B4), showed that co-cultured capsules consisted of 
encapsulated fibroblasts within the E3-PA fibrillar matrix (Fig. 6B3), confined by a layer 
of keratinocytes on the outer shell (Fig. 6B2). SEM micrographs showed that 
keratinocytes were fully adhered to the capsule shell, exhibiting extended filopodia 
and lamellipodia and interacting with the fibrillar surface of K3-PA (Fig. 6C). Our results 
showed that these capsules represent a good model to resemble the three-
dimensional architecture of in vivo tissues carrying different cell types. In addition, 
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these peptide-based capsules can be tailored in a highly controlled manner to mimic 
ECM properties and functions. For example, the peptides in the capsule outer shell and 
core can be customized for other cell types by incorporating specific peptide 
sequences and their composition can be tuned to obtain matrices with defined 
structure and stiffness for 3D cell culture.  
 
4. Conclusions 
Here we demonstrate the application of electrostatic self-assembly, between peptide 
amphiphiles, combined with microfluidics to guide the assembly into spherical 
capsules. These capsules present a core shell structure and their properties 
(nanofibrillar density, permeability, stiffness) can be tuned by varying the 
concentration of each peptide. By controlling the capsules properties, cell-matrix 
interactions can be studied in a 3D environment. Capsules composed of a simple 
negatively charged peptide, without any cell-adhesive sequence, were shown to 
support the survival of encapsulated human dermal fibroblasts. Another application of 
these capsules is demonstrated by co-culturing two cell types within and on their 
surface. The versatility of the selected building blocks to present bioactive ligands 
provides the opportunity to mimic other functionalities of the natural ECM, which can 
find numerous applications in cell biology and regenerative medicine. 
 
 
Acknowledgements 
Funding for this study was provided by the Portuguese Foundation for Science and 
Technology (FCT, grant PTDC/EBB-BIO/114523/2009). D.S. Ferreira gratefully 
Page 26 of 44Soft Matter
acknowledges FCT for the PhD scholarship (SFRH/BD/44977/2008). We also thank Dr 
A. C. Mendes from the 3B’s Research Group at the University of Minho (Portugal) for 
her assistance with the microfluidics device.  
Page 27 of 44 Soft Matter
5. References 
1. T. Aida, E. W. Meijer and S. I. Stupp, Science, 2012, 335, 813-817. 
2. S. I. Stupp, Nano Lett, 2010, 10, 4783-4786. 
3. R. M. Capito, H. S. Azevedo, Y. S. Velichko, A. Mata and S. I. Stupp, Science, 2008, 319, 
1812-1816. 
4. R. Haghgooie and P. S. Doyle, Soft Matter, 2009, 5, 1192-1197. 
5. C. W. Wang, D. Sinton and M. G. Moffitt, Acs Nano, 2013, 7, 1424-1436. 
6. D. W. P. M. Lowik, I. O. Shklyarevskiy, L. Ruizendaal, P. C. M. Christianen, J. C. Maan 
and J. C. M. van Hest, Adv Mater, 2007, 19, 1191-+. 
7. Y. S. Velichko, J. R. Mantei, R. Bitton, D. Carvajal, K. R. Shull and S. I. Stupp, Adv Funct 
Mater, 2012, 22, 369-377. 
8. S. M. Zhang, M. A. Greenfield, A. Mata, L. C. Palmer, R. Bitton, J. R. Mantei, C. Aparicio, 
M. O. de la Cruz and S. I. Stupp, Nat Mater, 2010, 9, 594-601. 
9. K. Sugihara, M. Chami, I. Derenyi, J. Voros and T. Zambelli, Acs Nano, 2012, 6, 6626-
6632. 
10. A. C. Mendes, K. H. Smith, E. Tejeda-Montes, E. Engel, R. L. Reis, H. S. Azevedo and A. 
Mata, Adv Funct Mater, 2013, 23, 430-438. 
11. B. A. Grzybowski, C. E. Wilmer, J. Kim, K. P. Browne and K. J. M. Bishop, Soft Matter, 
2009, 5, 1110-1128. 
12. R. Karnik, F. Gu, P. Basto, C. Cannizzaro, L. Dean, W. Kyei-Manu, R. Langer and O. C. 
Farokhzad, Nano Lett, 2008, 8, 2906-2912. 
13. A. Jahn, S. M. Stavis, J. S. Hong, W. N. Vreeland, D. L. DeVoe and M. Gaitan, Acs Nano, 
2010, 4, 2077-2087. 
14. A. C. Mendes, E. T. Baran, P. Lisboa, R. L. Reis and H. S. Azevedo, Biomacromolecules, 
2012, 13, 4039-4048. 
15. D. Seliktar, Science, 2012, 336, 1124-1128. 
16. E. Gazit, Nat Chem, 2010, 2, 1010-1011. 
17. E. Gazit, Chem Soc Rev, 2007, 36, 1263-1269. 
18. K. L. Niece, J. D. Hartgerink, J. J. J. M. Donners and S. I. Stupp, J. Am. Chem. Soc., 2003, 
125, 7146-7147. 
19. T. Savin and P. S. Doyle, Soft Matter, 2007, 3, 1194-1202. 
20. M. R. Caplan, P. N. Moore, S. G. Zhang, R. D. Kamm and D. A. Lauffenburger, 
Biomacromolecules, 2000, 1, 627-631. 
21. S. G. Zhang, T. Holmes, C. Lockshin and A. Rich, Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 
3334-3338. 
22. T. M. S. Chang, Nat Rev Drug Discov, 2005, 4, 221-235. 
23. D. Velasco, E. Tumarkin and E. Kumacheva, Small, 2012, 8, 1633-1642. 
24. S. Allazetta, T. C. Hausherr and M. P. Lutolf, Biomacromolecules, 2013. 
25. S. Seiffert, Chemphyschem, 2013, 14, 295-304. 
26. A. C. Mendes, E. T. Baran, R. L. Reis and H. S. Azevedo, Acta Biomater., 2013, 9, 6675-
6685. 
27. M. J. Webber, J. Tongers, M.-A. Renault, J. G. Roncalli, D. W. Losordo and S. I. Stupp, 
Acta Biomater., 2010, 6, 3-11. 
28. E. T. Pashuck, H. G. Cui and S. I. Stupp, J. Am. Chem. Soc., 2010, 132, 6041-6046. 
29. E. Beniash, J. D. Hartgerink, H. Storrie, J. C. Stendahl and S. I. Stupp, Acta Biomater., 
2005, 1, 387-397. 
30. S. G. Zhang, Nat. Biotechnol., 2003, 21, 1171-1178. 
31. M. Zhou, A. M. Smith, A. K. Das, N. W. Hodson, R. F. Collins, R. V. Ulijn and J. E. Gough, 
Biomaterials, 2009, 30, 2523-2530. 
32. M. D. Darrabie, W. F. Kendall Jr and E. C. Opara, Biomaterials, 2005, 26, 6846-6852. 
Page 28 of 44Soft Matter
33. A. D. Metcalfe and M. W. Ferguson, J R Soc Interface, 2007, 4, 413-437. 
34. K. Bott, Z. Upton, K. Schrobback, M. Ehrbar, J. A. Hubbell, M. P. Lutolf and S. C. Rizzi, 
Biomaterials, 2010, 31, 8454-8464. 
35. B. A. Roeder, K. Kokini, J. E. Sturgis, J. P. Robinson and S. L. Voytik-Harbin, J Biomech 
Eng, 2002, 124, 214-222. 
36. K. M. Yamada and E. Cukierman, Cell, 2007, 130, 601-610. 
37. E. Cukierman, R. Pankov, D. R. Stevens and K. M. Yamada, Science, 2001, 294, 1708-
1712. 
38. P. Friedl and E. B. Bröcker, CMLS, Cell. Mol. Life Sci., 2000, 57, 41-64. 
 
 
  
Page 29 of 44 Soft Matter
Figure 1. Capsule generation by directed self-assembly. Schematic representation of 
the set-up for capsule generation and cell encapsulation. The E3-PA microdroplets 
generated at the T-junction of the microfluidic system (A) were directly extruded into a 
solution of K3-PA for electrostatic self-assembly (B). At the droplets interface, self-
assembly immediately occurs resulting on the formation of a capsular structure (a wall 
membrane made of K3-E3-PA nanofibers with a liquefied core containing free E3-PA 
molecules (C). The K3-PA solution was supplemented with 0.1 M CaCl2 to induce the 
gelation of internal E3-PA (D). 
 
Figure 2. Capsules morphology and microstructure. Phase contrast microscopy images 
(A) and SEM micrographs (B) showing the size and overall structure of peptide-based 
capsules. SEM micrographs of capsule shell at higher magnification show a network of 
nanofibers randomly distributed with higher density for the capsules with higher 
concentration of K3-PA. SEM micrographs of capsule interior show a dense core with a 
random fibrillar structure (C). 
 
Figure 3. Capsules stability and permeability. Capsules stability in aqueous solutions 
(A) and mechanical resistance (B) as a function of K3-PA concentration. Capsule 
permeability assessed by the release of encapsulated dextran (fluorescently labeled) 
with different molecular weights (20, 40 and 155 kDa) (C). Scanning electron 
micrographs shows differences in network morphology and fiber density that depend 
on K3-PA concentration. (**) p< 0.01, (*) p< 0.05, error bars represent standard 
deviation 
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Figure 4. In vitro viability and proliferation of hDFb encapsulated within peptide-
based capsules. Cell proliferation assessed by dsDNA quantification (A) ((***) p< 
0.001, (*) p< 0.05, error bars represent standard deviation (n=3)) and fluorescence 
microscopy images of live/dead assay on encapsulated fibroblasts (B). Living cells were 
stained by calcein (green) and dead cells by propidium iodide (red). Scale bar 
represents 200 µm. Phase contrast microscopy of encapsulated fibroblasts in the 
capsules (C1) and confocal microscopy images of stained collagen I produced by hDFb 
during culture time (C2, C3). SEM micrographs of encapsulated cells show round-
shaped cells inside cavities (D). 
 
Figure 5. Influence of matrix composition on fibroblast morphology. SEM 
micrographs of the capsules interior revealed a higher density of fibrillar 
nanostructures with increasing concentration of E3-PA (A). Morphology of hDFb 
cultured within the peptide capsules revealed by SEM at day 14 (inset image shows the 
morphology of the cells at day 1) (B). Confocal microscopy images of stained collagen I 
(green) and f-actin (red) after 14 days, showed spread cells that formed a 3D-network 
with highly elongated cells in 0.5% E3-PA capsules (C). Cells cultured in 1 and 2 wt% E3-
PA capsules maintained a spherical shape, with peripheral deposition or poorly 
organized F-actin that followed the cell contours.  
 
Figure 6. Co-culture studies. Concept of co-culturing skin cells within and on the 
peptide-based capsules (A). Phase contrast image showing keratinocytes on the 
capsule surface (B1). Immunostaining of specific markers for each cell type confirmed 
the localization of the fibroblasts in the capsule interior (B3) and keratinocytes on the 
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surface (B2). SEM micrographs show keratinocytes fully adhered to the capsule shell, 
exhibiting extended filopodia and lamellipodia and interacting with the fibrillar surface 
(C). 
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Capsule generation by directed self-assembly. Schematic representation of the set-up for capsule generation 
and cell encapsulation. The E3-PA microdroplets generated at the T-junction of the microfluidic system (A) 
were directly extruded into a solution of K3-PA for electrostatic self-assembly (B). At the droplets interface, 
self-assembly immediately occurs resulting on the formation of a capsular structure (a wall membrane made 
of K3-E3-PA nanofibers with a liquefied core containing free E3-PA molecules (C). The K3-PA solution was 
supplemented with 0.1 M CaCl2 to induce the gelation of internal E3-PA (D).  
 
148x82mm (300 x 300 DPI)  
 
 
Page 33 of 44 Soft Matter
  
 
 
Capsules morphology and microstructure. Phase contrast microscopy images (A) and SEM micrographs (B) 
showing the size and overall structure of peptide-based capsules. SEM micrographs of capsule shell at higher 
magnification show a network of nanofibers randomly distributed with higher density for the capsules with 
higher concentration of K3-PA. SEM micrographs of capsule interior show a dense core with a random 
fibrillar structure(C).  
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Capsules stability and permeability. Capsules stability in aqueous solutions (A) and mechanical resistance 
(B) as a function of K3-PA concentration. Capsule permeability assessed by the release of encapsulated 
dextran (fluorescently labeled) with different molecular weights (20, 40 and 155 kDa) (C). Scanning electron 
micrographs shows differences in network morphology and fiber density that depend on K3-PA 
concentration. (**) p< 0.01, (*) p< 0.05, error bars represent standard deviation  
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In vitro viability and proliferation of hDFb encapsulated within peptide-based capsules. Cell proliferation 
assessed by dsDNA quantification (A) ((***) p< 0.001, (*) p< 0.05, error bars represent standard deviation 
(n=3)) and fluorescence microscopy images of live/dead assay on encapsulated fibroblasts (B). Living cells 
were stained by calcein (green) and dead cells by propidium iodide (red). Scale bar represents 200 µm. 
Phase contrast microscopy of encapsulated fibroblasts in the capsules (C1) and confocal microscopy images 
of stained collagen I produced by hDFb during culture time (C2, C3). SEM micrographs of encapsulated cells 
show round-shaped cells inside cavities (D).  
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Influence of matrix composition on fibroblast morphology. SEM micrographs of the capsules interior revealed 
a higher density of fibrillar nanostructures with increasing concentration of E3-PA (A). Morphology of hDFb 
cultured within the peptide capsules revealed by SEM at day 14 (inset image shows the morphology of the 
cells at day 1) (B). Confocal microscopy images of stained collagen I (green) and f-actin (red) after 14 days, 
showed spread cells that formed a 3D-network with highly elongated cells in 0.5% E3-PA (C). Cells cultured 
in 1 and 2 wt% E3-PA capsules maintained a spherical shape, with peripheral deposition or poorly organized 
F-actin that followed the cell contours.  
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Co-culture studies. Concept of co-culturing skin cells within and on the peptide-based capsules (A) Phase 
contrast image showing keratinocytes on the capsule surface (B1). Immunostaining of specific markers for 
each cell type confirmed the localization of the fibroblasts in the capsule interior (B3) and keratinocytes on 
the surface (B2). SEM micrographs show keratinocytes fully adhered to the capsule shell, exhibiting 
extended filopodia and lamellipodia and interacting with the fibrillar surface (C).  
228x346mm (300 x 300 DPI)  
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Peptide-based microcapsules obtained by self-assembly and microfluidics as 
controlled environments for cell culture 
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All peptides were synthesized, characterized and purified successfully. MALDI-MS was used to 
characterize the mass of the synthesized peptides (Fig. S1-S2, A). 
 
The expected mass for C16V3A3K3 (C58H111N13O10) was 1150.58, two main peaks were found by 
MALDI-MS, corresponding to [M] m/z = 1150.84, and [M+Na]
+
 m/z= 1172.83 (Fig. S1A). 
The expected mass for C16V3A3E3 (C55H95N9O17) was 1152.68, one main peak was found by 
MALDI-MS, m/z = 1152.80(Fig. S2A). 
 
Analytical HPLC of the collected fractions showed a single peak after purification for all the PAs 
(Fig. S1-S2, B) 
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C16V3A3K3 
 
 
 
Figure S1. Representative MALDI-MS data (A) and analytical HPLC trace, detected at 220 nm 
(B) of C16V3A3K3. 
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C16V3A3E3 
 
 
Figure S2. Representative MALDI-MS data (A) and analytical HPLC trace, detected at 220 nm 
(B) of C16V3A3E3. 
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 Figure S3. SEM micrographs of capsule external surface at different magnifications and as 
function of K3-PA concentration. 
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Capsule shell porosity was estimated using SEM micrographsa nd ImageJ sotware (NIH, USA) 
for image analysis and processing.
S1
 To separate the nanofibers from the background, a 
threshold was set to the image by assigning the pixels in the image as either completely white 
or black. Once the range was selected a binary image was created (Fig. S4) by the software in 
which objects (nanofibers) are white and background is black. The measurement tool was then 
used to quantify the area covered by the pores or by the nanofibers. Since the image area was 
known, the area fraction filled by the pores was calculated giving an estimated value of 
porosity. 
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%K3 
Estimated 
Porosity (%) 
0.1 64.4 
0.2 41.6 
0.5 23.1 
 
Figure S4. SEM micrographs of external surface of capsules prepared at different K3-PA 
concentrations and thresholded images processed with ImageJ software (A). Estimated 
porosity of capsule shell as function of K3-PA concentrations. 
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